
REVB Valuation
Revelation Biosciences Inc
- Overview
- Forecast
- Valuation
- Earnings
REVB Relative Valuation
REVB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, REVB is overvalued; if below, it's undervalued.
Historical Valuation
Revelation Biosciences Inc (REVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.76. The fair price of Revelation Biosciences Inc (REVB) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:2.86
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.34
P/B
Median3y
0.74
Median5y
-145.58
-390.51
FCF Yield
Median3y
-405.52
Median5y
-285.43
Competitors Valuation Multiple
The average P/S ratio for REVB's competitors is 4.46, providing a benchmark for relative valuation. Revelation Biosciences Inc Corp (REVB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

PTIX
Protagenic Therapeutics Inc
3.260
USD
+0.62%

SOPA
Society Pass Inc
1.250
USD
0.00%

STSS
Sharps Technology Inc
6.120
USD
-0.65%

RSLS
ReShape Lifesciences Inc
2.480
USD
-9.16%

FAMI
Farmmi Inc
1.850
USD
-2.12%

TNFA
TNF Pharmaceuticals Inc
0.117
USD
-11.36%

NDRA
ENDRA Life Sciences Inc
6.600
USD
+0.46%

HEPA
Hepion Pharmaceuticals Inc
0.170
USD
-23.27%

BENF
Beneficient
0.376
USD
-1.05%

WORX
Scworx Corp
0.427
USD
-3.40%
FAQ

Is Revelation Biosciences Inc (REVB) currently overvalued or undervalued?
Revelation Biosciences Inc (REVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.76. The fair price of Revelation Biosciences Inc (REVB) is between NaN to NaN according to relative valuation methord.

What is Revelation Biosciences Inc (REVB) fair value?

How does REVB's valuation metrics compare to the industry average?

What is the current P/B ratio for Revelation Biosciences Inc (REVB) as of Jul 25 2025?

What is the current FCF Yield for Revelation Biosciences Inc (REVB) as of Jul 25 2025?

What is the current Forward P/E ratio for Revelation Biosciences Inc (REVB) as of Jul 25 2025?
